DHSC: PCP: Evidence Summaries (4 lots) FY 24/25

A Tender Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE

Source
Find a Tender
Type
Contract (Services)
Duration
9 month
Value
£248K
Sector
PROFESSIONAL
Published
09 Sep 2024
Delivery
To 21 Jul 2025 (est.)
Deadline
21 Oct 2024 12:00

Concepts

Location

London

Geochart for 3 buyers and 0 suppliers

Description

The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.This contract has been divided into 4 lots. Each lot corresponds to the following lotsLot 1 Biliary atresia Lot 2 Group B strepLot 3 Breast Risk StratificationLot 4 Targeted ScreeningContract Project Reference: C294820Contract term: 9 months with the option to extend for up to further 2 months.Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs).

Lot Division

1 Biliary atresia
  • Value: £62K

The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. … More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot Lot 1 Biliary atresia

2 Group B strep
  • Value: £62K

The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. … More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 2 Group B strep

3 Decision analytic model for risk stratification in breast cancer screening
  • Value: £62K

The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. … More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 3 Decision Analytic Model for Risk Stratification

4 Targeted Screening
  • Value: £62K

The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. … More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 4 Targeted Screening

Renewal Options

Additional 2 months at the sole discretion of the Authority and no additional cost.

CPV Codes

  • 73200000 - Research and development consultancy services

Indicators

  • Restrictions apply to the lot award allocation.
  • Bids should cover one or more lots.
  • Bids should cover the whole contract.
  • Renewals are available.
  • Award on basis of price and quality.

Other Information

However, any selection of tenderers will be based solely on the criteria set out for the procurement.The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.Deadline for submission: 21st October 2024 at 12 noon

Reference

Domains